M. Moscovici
Impact in
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver physiology and pathology
- Hepatitis C virus research
-
- Cancer Mechanisms and Therapy
Papers in
- Hepatology 13
- Hepatocellular Carcinoma Treatment and Prognosis 13
- Liver physiology and pathology 3
-
- Lung Cancer Treatments and Mutations 7
- Co-authors
- Armando Santoro (8 shared papers)Sergio Ricci (3 shared papers)Jacques De Grève (4 shared papers)Arié Figer (4 shared papers)Chetan Lathia (3 shared papers)D. Voliotis (13 shared papers)Ghassan K. Abou‐Alfa (2 shared papers)Dino Amadori (2 shared papers)
- Journals
- Journal of Clinical Oncology (9 papers)Journal of Hepatology (3 papers)Annals of Oncology (3 papers)Pharmacopsychiatry (1 paper)European Journal of Cancer Supplements (2 papers)
- Partner nations
- United StatesItalyGermany
In The Last Decade
M. Moscovici
18 papers receiving 2.1k citations
M. Moscovici's Hit Papers
Peers
Comparison fields: 5 of 76
- Hepatology 1.5k
- Pathology and Forensic Medicine 589
- Cancer Research 365
- Oncology 462
- Epidemiology 584
Countries citing papers authored by M. Moscovici
This map shows the geographic impact of M. Moscovici's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Moscovici with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Moscovici more than expected).
Fields of papers citing papers by M. Moscovici
This network shows the impact of papers produced by M. Moscovici. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Moscovici. The network helps show where M. Moscovici may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Moscovici, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Phase II Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma Hit paper breakdown → | 2006 | 948 |
| 2 | Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial Hit paper breakdown → | 2012 | 656 |
| 3 | 2007 | 163 | |
| 4 | 2012 | 102 | |
| 5 | Safety and Efficacy of Sorafenib in Patients with Hepatocellular Carcinoma (HCC) and Child-Pugh A versus B Cirrhosis. | 2011 | 79 |
| 6 | 2008 | 45 | |
| 7 | 2007 | 24 | |
| 8 | 2008 | 20 | |
| 9 | Chemotherapies and targeted therapies in advanced hepatocellular carcinoma: from laboratory to clinic. | 2008 | 15 |
| 10 | 2008 | 15 | |
| 11 | 2004 | 15 | |
| 12 | 2008 | 10 | |
| 13 | 2008 | 8 | |
| 14 | 2010 | 7 | |
| 15 | 2004 | 6 | |
| 16 | 2015 | 3 | |
| 17 | 1980 | 2 | |
| 18 | 2016 | 1 | |
| 19 | 2004 | 1 | |
| 20 | 2016 | 0 |
About M. Moscovici
M. Moscovici is a scholar working on Hepatology, Pulmonary and Respiratory Medicine, Oncology, Epidemiology and Pathology and Forensic Medicine, having authored 20 papers that have together received 2.1k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Lung Cancer Treatments and Mutations (7 papers), Colorectal Cancer Treatments and Studies (6 papers), Liver Disease Diagnosis and Treatment (6 papers), Cancer Treatment and Pharmacology (5 papers), Cancer, Lipids, and Metabolism (3 papers), Cancer Mechanisms and Therapy (3 papers) and Liver physiology and pathology (3 papers). The work is most often cited by research in Hepatology (1.5k citations), Pathology and Forensic Medicine (589 citations), Cancer Research (365 citations), Oncology (462 citations) and Epidemiology (584 citations). M. Moscovici has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include Armando Santoro, Sergio Ricci, Jacques De Grève, Arié Figer, Chetan Lathia, D. Voliotis, Ghassan K. Abou‐Alfa, Dino Amadori, Leonard B. Saltz and Jean‐Yves Douillard. Their work appears in journals such as Journal of Clinical Oncology, Journal of Hepatology, Annals of Oncology, Pharmacopsychiatry and European Journal of Cancer Supplements.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.